Opioid Free Anesthesia in Prolonged Surgery
Cancer, Bladder
About this trial
This is an interventional supportive care trial for Cancer, Bladder focused on measuring Opioid-Free Anaesthesia, Prolonged Orthotopic Urinary Bladder Diversion Surgery, Intrathecal dexmedetomidine
Eligibility Criteria
Inclusion Criteria:
- Patients scheduled for orthotopic urinary bladder diversion prolonged surgery procedures.
- American society of Anaethesiologists (ASA I-II).
- Both sexes.
- Age 18 - 70 years.
Exclusion Criteria:
- Patient refusal.
- Hypersensitivity to amide local anesthetics or opioids as fentanyl.
- General contraindications to spinal and epidural anaesthesia as thrombocytopenia, coagulopathy and severe dehydration.
- Uncompensated Cardiac or hepatic patients.
- Renal failure or respiratory failure patients.
Sites / Locations
- Medicine
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Epidural Fentanyl group:
Intrathecal dexmedetomidine group:
Epidural Fentanyl group: using an epidural catheter technique with epidural catheter set, and at L1-2 insertion level directed up to cover up to T6 sensory level, 5ml of bupivacaine 0.5%plus 50 micrograms fentanyl in a total volume of 40 ml added saline 0.9% (epidural injection of bolus of total Volume of 15 ml of 0.0625%bupivacaine with 1.25Mcg/ml fentanyl) then for next G anaesthesia hours to run in a 3-5 ml/h epidural infusion rate.
Intrathecal dexmedetomidine plus heavy bupivacaine then general A